2493 related articles for article (PubMed ID: 17692723)
1. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
2. Phase 4 study to assess tretinoin pump for the treatment of facial acne.
Eichenfield LF; Nighland M; Rossi AB; Cook-Bolden F; Grimes P; Fried R; Levy S;
J Drugs Dermatol; 2008 Dec; 7(12):1129-36. PubMed ID: 19137766
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
4. Tretinoin microsphere gel in facial acne vulgaris: a meta-analysis.
Nighland M; Grossman R
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s2-8. PubMed ID: 18724648
[TBL] [Abstract][Full Text] [Related]
5. Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris.
Kircik LH
J Drugs Dermatol; 2009 Jul; 8(7):650-4. PubMed ID: 19588641
[TBL] [Abstract][Full Text] [Related]
6. Tretinoin microsphere gel in younger acne patients.
Jorizzo J; Grossman R; Nighland M
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s9-13. PubMed ID: 18724649
[TBL] [Abstract][Full Text] [Related]
7. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
9. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
Leyden JJ; Tanghetti EA; Miller B; Ung M; Berson D; Lee J
Cutis; 2002 Feb; 69(2 Suppl):12-9. PubMed ID: 12095064
[TBL] [Abstract][Full Text] [Related]
10. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.
Webster GF; Berson D; Stein LF; Fivenson DP; Tanghetti EA; Ling M
Cutis; 2001 Jun; 67(6 Suppl):4-9. PubMed ID: 11499329
[TBL] [Abstract][Full Text] [Related]
12. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
13. Tretinoin microsphere gel 0.04% pump for treating acne vulgaris in preadolescents: a randomized, controlled study.
Eichenfield LF; Hebert AA; Schachner L; Paller AS; Rossi AB; Lucky AW
Pediatr Dermatol; 2012; 29(5):598-604. PubMed ID: 22712470
[TBL] [Abstract][Full Text] [Related]
14. Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
Leyden JJ; Nighland M; Rossi AB; Ramaswamy R
J Drugs Dermatol; 2010 Aug; 9(8):998-1003. PubMed ID: 20684151
[TBL] [Abstract][Full Text] [Related]
15. Comparison of micronized tretinoin gel 0.05% and tretinoin gel microsphere 0.1% in young adolescents with acne: a post hoc analysis of efficacy and tolerability data.
Lucky AW; Sugarman J
Cutis; 2011 Jun; 87(6):305-10. PubMed ID: 21838089
[TBL] [Abstract][Full Text] [Related]
16. A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults.
Berger R; Barba A; Fleischer A; Leyden JJ; Lucky A; Pariser D; Rafal E; Thiboutot D; Wilson D; Grossman R; Nighland M
Cutis; 2007 Aug; 80(2):152-7. PubMed ID: 17944177
[TBL] [Abstract][Full Text] [Related]
17. Photographic assessment of tretinoin microsphere gel in moderate acne.
Feldman S; Nighland M
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s19-24. PubMed ID: 18724651
[TBL] [Abstract][Full Text] [Related]
18. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
Nyirady J; Grossman RM; Nighland M; Berger RS; Jorizzo JL; Kim YH; Martin AG; Pandya AG; Schulz KK; Strauss JS
J Dermatolog Treat; 2001 Sep; 12(3):149-57. PubMed ID: 12243706
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
